Extract notice to the Minister
Steqeyma (indications diverses, nouvelle forme)
Common name / Subject : ustekinumab
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (stylo)
Dosage : 45 mg / 0,5 ml, 90 mg / 1 ml
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (stylo)
Dosage : 45 mg / 0,5 ml, 90 mg / 1 ml
Indication : Arthrite psoriasique, Colite ulcéreuse, Maladie de Crohn et Psoriasis en plaques (adulte & pédiatrie) (nouvelle forme)
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
À venir
Evaluation published on July 28, 2026
INESSSid: 30094
Recevable on March 16, 2026